Amundi Asset Management US’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Amundi Asset Management US’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$16.5M	Buy	179,491 +38,188	+27%	+$3.22M	0.01%	719
2020 Q4	$10.3M	Buy	141,303 +69,547	+97%	+$5.17M	0.01%	792
2020 Q3	$5.57M	Buy	71,756 +57,156	+391%	+$3.93M	0.01%	868
2020 Q2	$811K	Hold	14,600	–	–	﹤0.01%	1200
2020 Q1	$432K	Sell	14,600 -4,800	-25%	-$162K	﹤0.01%	1222
2019 Q4	$702K	Hold	19,400	–	–	﹤0.01%	1289
2019 Q3	$528K	Buy	19,400 +13,300	+218%	+$344K	﹤0.01%	1316
2019 Q2	$147K	Hold	6,100	–	–	﹤0.01%	1525
2019 Q1	$161K	Sell	6,100 -18,100	-75%	-$429K	﹤0.01%	1474
2018 Q4	$473	Sell	24,200 -23,800	-50%	-$467K	﹤0.01%	1273
2018 Q3	$940K	Sell	48,000 -394,300	-89%	-$7.5M	﹤0.01%	1269
2018 Q2	$7.32M	Buy	+442,300	New	+$6.74M	0.01%	813

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Amundi Asset Management US's HZNP Position: Q1 2021 in Review

Amundi Asset Management US increased its Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) stake by 27% in Q1 2021, buying an estimated $3.22M and bringing the position to 179,491 shares worth $16.5M. The position accounts for 0.01% of the portfolio, ranked #719.

Amundi Asset Management US first reported a position in HZNP in Q2 2018 and has held it in 12 quarters since. 516 funds tracked by Wall St. Rank hold HZNP as of Q1 2021.

Amundi Asset Management US held 179,491 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $16.5M as of Q1 2021.
Amundi Asset Management US bought 38,188 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2021, an estimated $3.22M.
Horizon Therapeutics Public Limited Company Ordinary Shares made up 0.01% of Amundi Asset Management US's portfolio in Q1 2021, its #719 holding.
Amundi Asset Management US first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2018 and has held it in 12 quarters since.
516 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.